Thursday, July 30

Browsing: Vepdegestrant

Support

FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer

By NewsCancerMay 1, 20260

The FDA has approved vepdegestrant (Veppanu) for patients with estrogen receptor (ER)–positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer, which…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Browsing: Vepdegestrant

FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Linvoseltamab Data and Clinical Perspectives in Relapsed/Refractory Multiple Myeloma

Latest Post

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer

Subscribe to Updates

What's Hot

Browsing: Vepdegestrant